CXD-201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCXD-201
Drug Alias NameCXD-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIngenOx Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIngenOx Therapeutics LtdNuance Biotech Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A